Norway Savings Bank’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,121
| Closed | -$211K | – | 107 |
|
|
2024
Q4 | $211K | Buy |
2,121
+131
| +7% | +$13.5K | 0.12% | 105 |
|
|
2024
Q3 | $226K | Sell |
1,990
-155
| -7% | -$18.4K | 0.12% | 101 |
|
|
2024
Q2 | $266K | Hold |
2,145
| – | – | 0.15% | 96 |
|
|
2024
Q1 | $283K | Sell |
2,145
-75
| -3% | -$9.24K | 0.12% | 125 |
|
|
2023
Q4 | $242K | Buy |
2,220
+140
| +7% | +$14.5K | 0.11% | 130 |
|
|
2023
Q3 | $214K | Buy |
+2,080
| New | +$224K | 0.11% | 129 |
|
|
2023
Q2 | – | Sell |
-3,032
| Closed | -$323K | – | 138 |
|
|
2023
Q1 | $323K | Sell |
3,032
-337
| -10% | -$36.4K | 0.16% | 113 |
|
|
2022
Q4 | $374K | Sell |
3,369
-16
| -0.5% | -$1.64K | 0.19% | 109 |
|
|
2022
Q3 | $291K | Sell |
3,385
-805
| -19% | -$71.9K | 0.16% | 118 |
|
|
2022
Q2 | $382K | Sell |
4,190
-25
| -0.6% | -$2.22K | 0.2% | 111 |
|
|
2022
Q1 | $346K | Sell |
4,215
-207
| -5% | -$16.3K | 0.16% | 123 |
|
|
2021
Q4 | $339K | Sell |
4,422
-533
| -11% | -$42.5K | 0.15% | 122 |
|
|
2021
Q3 | $372K | Sell |
4,955
-744
| -13% | -$56.6K | 0.18% | 112 |
|
|
2021
Q2 | $443K | Sell |
5,699
-798
| -12% | -$59.4K | 0.22% | 100 |
|
|
2021
Q1 | $478K | Buy |
6,497
+1,515
| +30% | +$112K | 0.25% | 93 |
|
|
2020
Q4 | $389K | Buy |
4,982
+780
| +19% | +$59.7K | 0.22% | 92 |
|
|
2020
Q3 | $332K | Sell |
4,202
-63
| -1% | -$4.93K | 0.22% | 96 |
|
|
2020
Q2 | $315K | Sell |
4,265
-89
| -2% | -$6.7K | 0.23% | 91 |
|
|
2020
Q1 | $320K | Buy |
4,354
+83
| +2% | +$6.52K | 0.28% | 83 |
|
|
2019
Q4 | $371K | Buy |
4,271
+27
| +0.6% | +$2.22K | 0.27% | 87 |
|
|
2019
Q3 | $341K | Hold |
4,244
| – | – | 0.28% | 85 |
|
|
2019
Q2 | $339K | Buy |
4,244
+1,950
| +85% | +$149K | 0.29% | 78 |
|
|
2019
Q1 | $182K | Hold |
2,294
| – | – | 0.16% | 98 |
|
|
2018
Q4 | $167K | Buy |
2,294
+10
| +0.4% | +$706 | 0.16% | 101 |
|
|
2018
Q3 | $155K | Hold |
2,284
| – | – | 0.14% | 105 |
|
|
2018
Q2 | $132K | Sell |
2,284
-230
| -9% | -$13K | 0.12% | 110 |
|
|
2018
Q1 | $131K | Sell |
2,514
-162
| -6% | -$8.75K | 0.12% | 111 |
|
|
2017
Q4 | $144K | Hold |
2,676
| – | – | 0.14% | 109 |
|
|
2017
Q3 | $163K | Sell |
2,676
-52
| -2% | -$3.15K | 0.16% | 104 |
|
|
2017
Q2 | $167K | Sell |
2,728
-52
| -2% | -$3.17K | 0.16% | 104 |
|
|
2017
Q1 | $169K | Sell |
2,780
-304
| -10% | -$18.4K | 0.17% | 99 |
|
|
2016
Q4 | $173K | Buy |
+3,084
| New | +$180K | 0.16% | 99 |
|
Other funds holding MRK
Norway Savings Bank's MRK Position: Q1 2025 in Review
Norway Savings Bank sold out of Merck (MRK) in Q1 2025, closing a stake of 2,121 shares — an estimated $211K sold.
Norway Savings Bank first reported a position in MRK in Q4 2016 and held it in 32 quarters. The position peaked at $478K in Q1 2021. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Norway Savings Bank reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
- Norway Savings Bank sold 2,121 Merck shares in Q1 2025, an estimated $211K.
- Norway Savings Bank first reported a position in Merck in Q4 2016 and held it in 32 quarters.
- Norway Savings Bank's Merck position peaked at $478K in Q1 2021.
- 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Norway Savings Bank's 13F filing for Q1 2025, filed 22 Apr 2025.